Celestial Oncology Competitors and Similar CompaniesClear all

ViewRay's competitors and similar companies include Elekta, .decimal and LinaTech.

	ViewRay ViewRay is a company that designs, manufactures, and markets MRIdian, an MRI-guided radiation therapy system.	Elekta Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders.	.decimal .decimal is a manufacturer of beam-shaping devices for proton, electron, and photon therapies to treat cancer.	LinaTech LinaTech is a company that manufactures medical devices and software for treating cancer with radiotherapy.
Founding Date	Founding Date 2004	Founding Date 1972	Founding Date 1986	Founding Date 1996
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Technology medtech oncology therapy	Tags Technology medtech oncology therapy	Tags Healthcare medical devices	Tags Healthcare enterprise software medical devices medtech oncology
Locations	Locations Oakwood Village, US HQ Mountain View, US	Locations Stockholm, SE HQ North Sydney, AU Innsbruck, AT Zaventem, BE São Paulo, BR Montréal, CA Beijing, CN see more	Locations Sanford, US HQ	Locations Sunnyvale, US HQ Tervuren, BE Suzhou Shi, CN
Employees	Employees 29510% increase	Employees 4,541	Employees 90	Employees 400
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.4 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $102.2m (FY, 2022)	Revenue (est.) kr18b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $92.2m (FY, 2022)	Cost of goods kr11.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $10m (FY, 2022)	Gross profit kr6.9b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($107.3m) (FY, 2022)	Net income kr240m (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 18k (over 5 years ago)	Latest funding round $ 2.9m (over 7 years ago)
Total funding raised	Total funding raised $ 84.8m	Total funding raised N/A	Total funding raised $ 2.3m	Total funding raised $ 2.9m